Bayer AG, maker of the antibleeding drug Trasylol, has announced that worldwide sales of the drug will be brought to a halt due to a clinical study linking Trasylol with a higher risk of death.
Read Full Article Here
FDA Requires Black Box Warning for Avandia
October 16, 2015 by
Due to the risk of congestive heart failure, the FDA is requiring that the type 2 diabetes drug Avandia be labeled with a black box warning detailing the risks.
FDA Approves Cefotetan and Dextrose for Duplex Drug Delivery System
October 16, 2015 by
Duplex is now the only ready-to-use IV drug delivery system available for Cefotetan therapy in the United States.
